久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

美國Ligand  
Ligand公司發(fā)現(xiàn)、開發(fā)新型藥物，以滿足下列多種疾病領(lǐng)域未獲滿足的緊迫醫(yī)療需求：肝炎、肌肉退行性變、阿爾茨海默病、血脂異常、糖尿病、貧血、COPD、哮喘、類風(fēng)濕性關(guān)節(jié)炎和骨質(zhì)疏松。Ligand公司的專利藥物發(fā)現(xiàn)和開發(fā)項目采用了先進的細胞檢測、組織特異性受體配體相互作用和基因表達工具。Ligand公司認為其擁有同類公司中最強大的資產(chǎn)陣容之一，包括與制藥企業(yè)通過伙伴關(guān)系開發(fā)的商業(yè)化療法。Ligand公司與世界領(lǐng)先的制藥企業(yè)建立了多項聯(lián)盟，包括葛蘭素史克、默克、輝瑞、百時美施貴寶和阿斯利康，不同階段的開發(fā)項目超過30個


Ligand Pharmaceuticals is located in La Jolla, California on the cliffs just above Torrey Pines Beach. Founded in 1987, Ligand is a biotech company with a rich heritage in drug discovery and development. Ligand has used its drug development expertise to produce over 40 clinical candidates, 22 INDs, and 5 approved drugs. That's a level of productivity that ranks near the top of the biotech industry.

Today, Ligand is operating with a lean and highly focused team, the vast majority of which work in drug discovery research. We are driven by our belief that we can discover new and important medicines and generate significant financial returns for investors.